Mandatory disclosure of trade by primary insiders or close associates in IDEX Biometrics

Reference is made to IDEX Biometrics ASA's disclosure on 4 December 2025 of a private placement of 7,333,333 shares at NOK 3.00 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders and In tranche 1 of the private placement includes 5,690,970 shares. K-konsult AS, a company closely related to chair Morten Opstad, subscribed to 83,333 shares, ISIN NO0013536078, at NOK 3.00 per share. Morten Opstad, chair, subscribed to 100,000 shares, ISIN NO0013536078, at NOK 3.00 per share Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 50,000 shares, ISIN NO0013536078, at NOK 3.00 per share. Contacts Anders Storbråten, CEO and CFO, Tel: +47 416 38 582 E-mail: ir@idexbiometrics.com About Us IDEX Biometrics ASA (OSE: IDEX) is shaping the future of access and payments. IDEX Biometrics is advancing the future of access and payments with identity-first biometrics. With over a decade of proprietary innovation, our solutions are proven in the field, globally certified, and trusted by leading financial institutions. We serve enterprises, the public sector, banks, and issuers directly and through partners, delivering secure, seamless experiences in digital and physical access and payments. For more information, visit www.idexbiometrics.com (http://www.idexbiometrics.com/) This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-12-08 23:30 CET.